Drug Profile
Research programme: diarrhoea therapies - Roche/OneWorld Health
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Institute for OneWorld Health; Roche
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diarrhoea
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diarrhoea(In children, In infants) in USA
- 18 Apr 2008 Early research in Diarrhoea in USA (unspecified route)